Table 3.
General characteristics of IRB protocols
| Number of protocols N (%) |
|
|---|---|
| (n = 240) | |
| Population proposed for investigation | |
| Males | 8 (3.3) |
| Females | 26 (10.8) |
| Both | 205 (85.4) |
| Not applicable | 1 (0.4) |
| Type of IRB review | |
| Full | 209 (87.1) |
| Expedited | 26 (10.8) |
| Exempt | 5 (2.1) |
| Type of data to be studied | |
| New data | 231 (96.3) |
| Existing population database | 9 (3.8) |
| Funding source | |
| No funding | 57 (23.8) |
| National Institutes of Health | 30 (12.5) |
| Foundation | 15 (6.3) |
| Penn Internal Grant or Funds | 12 (5.0) |
| Pharmaceutical | 91 (37.9) |
| Other funding | 42 (17.5) |
| Mention of keywords | |
| Mention “sex” or “gender” | 45 (18.8) |
| Mention “male,” “female,” “men,” or “women” | 155 (64.6) |
| Mention at least one of the following: “sex,” “gender,” “male,” “female,” “men,” and “women” | 165 (68.8) |
| Area of investigation | |
| Behavioral/neurological/psychological | 46 (19.2) |
| Medicine | 70 (29.2) |
| Surgery | 35 (14.6) |
| Oncology | 73 (30.4) |
| Obstetrics and gynecology | 9 (3.8) |
| Genetics | 4 (1.7) |
| Pediatrics | 3 (1.3) |
| Location of keywords within protocol | |
| (n = 165) | |
| Objectives | 17 (10.3) |
| Background | 19 (11.5) |
| Study design | 12 (7.3) |
| Populations | 32 (19.4) |
| Inclusions/exclusions | 142 (86.1) |
| Procedures | 8 (4.8) |
| Other | 6 (3.6) |